Tatva Chintan Pharma Chem (543321) Stock Overview
Engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 543321 from our risk checks.
543321 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Tatva Chintan Pharma Chem Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,204.80 |
| 52 Week High | ₹1,603.60 |
| 52 Week Low | ₹674.00 |
| Beta | 0.34 |
| 1 Month Change | 4.81% |
| 3 Month Change | -5.92% |
| 1 Year Change | 73.25% |
| 3 Year Change | -26.98% |
| 5 Year Change | n/a |
| Change since IPO | -47.85% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543321 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 8.1% | 6.4% | 6.9% |
| 1Y | 73.3% | -2.4% | 7.0% |
Return vs Industry: 543321 exceeded the Indian Chemicals industry which returned -2.4% over the past year.
Return vs Market: 543321 exceeded the Indian Market which returned 7% over the past year.
Price Volatility
| 543321 volatility | |
|---|---|
| 543321 Average Weekly Movement | 8.2% |
| Chemicals Industry Average Movement | 7.1% |
| Market Average Movement | 7.3% |
| 10% most volatile stocks in IN Market | 10.3% |
| 10% least volatile stocks in IN Market | 4.7% |
Stable Share Price: 543321 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 543321's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 679 | Chintan Shah | www.tatvachintan.com |
Tatva Chintan Pharma Chem Limited engages in the manufacture and sale of specialty chemicals in India, Germany, the United States of America, China, Singapore, and internationally. It offers structure directing agents (SDAs); phase transfer catalysts (PTCs); electrolyte salts for super capacitor batteries; pharmaceutical and agrochemical intermediates, and other specialty chemicals (PASC); and brominated flame retardants. The company serves automotive, refinery, pharmaceutical, agrochemicals, paints and coatings, dyes and pigments, personal care, and flavors and fragrances sectors.
Tatva Chintan Pharma Chem Limited Fundamentals Summary
| 543321 fundamental statistics | |
|---|---|
| Market cap | ₹28.12b |
| Earnings (TTM) | ₹327.63m |
| Revenue (TTM) | ₹4.80b |
Is 543321 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543321 income statement (TTM) | |
|---|---|
| Revenue | ₹4.80b |
| Cost of Revenue | ₹2.33b |
| Gross Profit | ₹2.47b |
| Other Expenses | ₹2.14b |
| Earnings | ₹327.63m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 14.01 |
| Gross Margin | 51.40% |
| Net Profit Margin | 6.83% |
| Debt/Equity Ratio | 11.0% |
How did 543321 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/12 14:56 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Tatva Chintan Pharma Chem Limited is covered by 4 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sanjesh Jain | ICICI Securities Ltd. |
| Anshuman Gupta | Investec Bank plc (UK) |
| Krishanchandra Parwani | JM Financial Institutional Securities Limited |